Delta GREENS Food is Medicine Intervention
Though the Mississippi Delta has a rich agricultural history and some of the nation's most fertile soil, residents have experienced the legacy of slavery and economic exploitation through food insecurity and poverty for generations. This project focuses on Bolivar, Washington, and Sunflower, contiguous counties in the Delta that are designated as health disparity populations. Over 65% of the 100,000 residents are Black/African American and \~30% live at or below the poverty level. Obesity rates are high and the rate of diabetes is almost double the national average. Tufts University received a grant from the National Institute of Minority Health and Health Disparities to develop, test, and evaluate a Food is Medicine program in Mississippi. The Delta Growing a Resilient, Enriching, Equitable, Nourishing food System (GREENS) Food is Medicine (FIM) Project, is a collaborative project in Bolivar, Washington, and Sunflower counties in Mississippi. The intervention involves regularly distributed fruit and vegetable produce boxes as well as nutrition education materials to the intervention group. The control group will receive produce boxes later, after they complete study activities. The project's primary goal is to improve health outcomes by creating a FIM intervention. The Delta GREENS FIM Project aims to become a model for promoting nutrition security and management of chronic conditions in varied communities nationwide.
Conditions:
🦠 Cardiometabolic Risk Factors
🦠 Diabetes
🦠 High Blood Pressure
🦠 Obesity
🦠 Nutrition Security
🗓️ Study Start (Actual)
20 May 2024
🗓️ Primary Completion (Estimated)
April 2026
✅ Study Completion (Estimated)
April 2026
👥 Enrollment (Estimated)
300
🔬 Study Type
INTERVENTIONAL
📊 Phase
NA
Locations:
📍
Boston, Massachusetts, United States
Description
Inclusion Criteria:
- * Patient at participating Delta Health Center (DHC) clinics
- * BMI: ≥ 25
- * Hemoglobin A1C (HbA1c): \>5.7 to 8.5%, inclusive
Exclusion Criteria:
- * Type 1 diabetes
- * Current use of incretin agonists (e.g., semaglutide, dulaglutide, liraglutide)
- * Uncontrolled hypertension:
- * Systolic blood pressure \> 160 mmHg
- * Diastolic blood pressure \> 100 mmHg
- * Severe symptomatic cardiovascular disease
- * Recent (6 months) history of:
- * Myocardial infarction
- * Percutaneous coronary intervention
- * Coronary artery bypass graft
- * Cerebrovascular disease
- * Participant in diabetes, nutrition, or weight intervention research in the last 12 months
- * Another family member or household member is a study participant
- * History of bariatric surgery or considering bariatric surgery in the next year or prior bariatric surgery
- * Lack of safe, stable residence and ability to store produce
- * Lack of telephone
- * Pregnancy/breastfeeding or intended pregnancy in the next year
- * Drug or alcohol misuse that would impair the ability to complete study activities
- * Known psychosis or major psychiatric illness that prevents participation in study activities
- * Any other reason that in the investigators' best judgment places the participants at risk or increases likelihood of poor adherence
Ages Eligible for Study:
21 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Yes
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported
results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before
being posted on the public website.
Study Registration Dates
- First Submitted
4 April 2024
- First Submitted that Met QC Criteria
8 April 2024
- First Posted
11 April 2024
Study Record Updates
- Last Update Submitted that Met QC Criteria
30 May 2024
- Last Update Posted
3 June 2024
- Last Verified
May 2024